UK Stocks-Factors to watch on Jan 17

Jan 17 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 21 points higher at 7,564 on Monday, according to financial bookmakers, while futures FFIc1 marginally down 0.4%.

* CLINIGEN: Britain's Clinigen Group CLINC.L has agreed to a sweetened takeover offer by UK-based private equity firm Triton, valuing the pharmaceutical services firm at about 1.3 billion pounds.

* OXFORD BIOMEDICA: Cell therapy firm Oxford Biomedica OXB.L said its Chief Executive Officer John Dawson plans to retire.

* UNILEVER: Unilever ULVR.L defended its approach for the consumer healthcare arm of GSK, saying the business was a "strong strategic fit" in line with its plan to expand in the health, beauty and hygiene categories.

* TAYLOR WIMPEY: Taylor Wimpey TW.L , UK's third-largest housebuilder, joined bigger rival Persimmon Plc PSN.L in underscoring sustained demand in the housing market after the company built more homes in the country in 2021 than the year-ago period.

* ALPHAWAVE: Semiconductor technology company Alphawave AWE.L reported $25.5 million in fourth-quarter new bookings, taking its total for the year to $244.7 million, which it said was ahead of the target it outlined at its listing in May.

* BARCLAYS: Britain's Barclays BARC.L appointed Duncan Beattie and Duncan Connellan as managing directors for its Australian investment banking arm, to help the bank expand its business in the country.

* GSK: GlaxoSmithKline GSK.L on Saturday said it had rejected a 50-billion-pound offer from Unilever ULVR.L for its consumer goods arm, saying it "fundamentally undervalued" the business and its future prospects and that it would stick to its plan of spinning off the unit.

* OIL: Oil prices rose, with Brent crude futures at their highest in more than three years, as investors bet supply will remain tight amid restrained output by major producers with global demand unperturbed by the Omicron coronavirus variant.

* UK shares slid on Friday, reflecting weak investor sentiment in global markets on fears about faster U.S. interest rate hikes, although data pointing to a much stronger-than-expected economic recovery in November helped limit losses.

* For more on the factors affecting European stocks, please click on:


> Financial Times

> Other business headlines

Reporting by Sinchita Mitra and Shanima A in Bengaluru

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。


本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。